Experiment for the treatment of Leishmaniasis of the skin with two drugs, Pentamidine and Tamoxife
Phase 2
- Conditions
- Cutaneous leishmaniasisCapítulo I
- Registration Number
- RBR-7y2gbdf
- Lead Sponsor
- Silmara Navarro Pennini
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Aged from 18 to 65 years; diagnosis of Cutaneous Leishmaniasis confirmed by direct parasitological examination; with a maximum of six lesions; without previous treatment
Exclusion Criteria
Women of childbearing age not using contraceptives; pregnant; lactating women; patients who had already had leishmaniasis; presence of comorbidities; patients under treatment with immunosuppressants or drugs that prolong the QT interval; patients with difficulties in attending planned visits in the study
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method